How much funding has Lyndra Therapeutics, Inc. raised?

Lyndra Therapeutics, Inc. has raised $259.8M in total funding, most recently a Series E round.

Who are Lyndra Therapeutics, Inc.'s investors?

Lyndra Therapeutics, Inc.'s investors include Polaris Partners, Sarissa Capital, Sun Pharma, Gilead Sciences, HOPU Investment Management.

When was Lyndra Therapeutics, Inc. founded?

Lyndra Therapeutics, Inc. was founded in 2016.

Where is Lyndra Therapeutics, Inc. headquartered?

Lyndra Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.

What industry is Lyndra Therapeutics, Inc. in?

Lyndra Therapeutics, Inc. operates in Biotech, Healthcare.

How many employees does Lyndra Therapeutics, Inc. have?

Lyndra Therapeutics, Inc. has 51-200 employees.

Lyndra Therapeutics, Inc.

What if we stopped trying to change the patient and changed the pill instead?

Watertown, United States · Founded 2016 · $259.8M raised

Biotech

Healthcare

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: lyndra.com
Total Funding: $259.8M
Last Round: $101.0M Series EDec 2023
Rounds: 5

About

Lyndra Therapeutics was a clinical-stage biopharmaceutical company dedicated to developing long-acting oral therapies using its proprietary LYNX platform. Founded from technology developed at MIT, the platform enables a single pill to deliver medication over a week or longer, improving patient adherence across therapeutic areas including HIV, psychiatry, and contraception. The company ceased operations in March 2025 after raising over $380M.

Summary

Lyndra Therapeutics, Inc. is a Biotech company based in Watertown, United States, founded in 2016. It has raised $259.8M in total across 5 rounds, most recently a $101.0M Series E round in Dec 2023. Investors include Polaris Partners, Sarissa Capital and Sun Pharma.